References
- Suchule J, Bergkvist L, Hakansson L, Gustafsson B, Hakansson A. Down regulation of the CD3-zeta chain in sentinel node biopsies from breast cancer patients. Breast Cancer Res Treat 2002; 74: 33–40.
- Shibuya TY, Nugyen N, McLaren CE, Li KT, Wei WZ, Kim S, Yoo GH, Rogowski A, Ensley J, Sakr W. Clinical significance of poor CD3 response in head and neck cancer. Clin Cancer Res 2002; 8: 745–751.
- Rossi E, Matutes E, Morilla R, Owusu-Ankomah K, Heffernan AM, Catovsky D. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukaemia. Leukemia 1996; 10: 494–497.
- Torelli GF, Paolini R, Tatarelli C, Soriani A, Vitale A, Guarini A,Santoni A, Foa R. Defective expression of the T-cell receptor CD3-zeta chain in T-cell acute lymphoblastic leukaemia. Br J Haematol 2003; 120: 201–208.
- Frydecka I, Bocko D, Kosmaczewska A, Ciszak L, Morilla R. Theeffect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2-production in Hodgkin's disease. Br J Cancer 2001; 84: 1339–1343.
- Atkinson TP, Hall CG, Goldsmith J, Kirkham PM. Splice variantin TCR-ZETA links T cell receptor signaling to a G-protein-related signaling pathway. Biochem and Biophysi Res Commun 2003; 310: 761–766.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2—AAct Method. Methods 2001; 25: 402–408.
- Krishnan S, Warke VG, Nambiar MP, Tsokos GC, Farber DL. The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells. Immunol 2003; 170: 4189–4194.
- Mizoguchi H, O'Shea ii, Longo DL, Loeffler CM, McVicar DW,Ochoa AC. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992; 258: 1795–1798.
- Solomou EE, Wong S, Visconte V, Gibellini F, Young NS. Decreased TCR zeta-chain expression in T cells from patients with acquired aplastic anaemia. Br J Haematol 2007; 138: 72–76.
- Li Y, Chen S, Yang L, Zhou X, Wu X, Huang M, Geng S. Clonal expanded TCR Vf T cells in patients with APL. Hematology 2005; 10: 135–139.
- Geng SX, Li YQ, Chen SH, Yang Li, Yin QS, Wu XL, Zhang XL. Peripheral blood naive T cell level and its T cell receptor WI repertoire usage profile in patients with chronic myelogenous leukemia. Zhonghua Xue Ye Xue Za Zhi 2005; 26: 413–416.
- Chen X, Woiciechowsky A, Raffegerst S, Schendel D, Kolb Hi, Roskrow M. Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. Br J Haematol 2000; 111: 817–825.
- Duriagin S, Ofori H, Jagodzifiski PP. Flow cytometric analysis of CD4± T cell receptor zeta chain deficiency in patients with systemic lupus erythematosus. Adv Med Sci 2006; 51: 181–183.
- de Paola F, Ridolfi R, Riccobon A, Flamini E, Barzanti F, Granato AM, Mordenti GL, Medri L, Vitali P, Amadori D. Restored T-cell activation mechanisms in human tumour-infiltrat-ing lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2. Br J Cancer 2003; 88: 320–326.
- Renner C, Ohnesorge S, Held G, Bauer S, Jung W, Pfitzenmerier JP, Pfreundschuh M. T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood 1996; 88: 236–241.